PRODUCT DETAILS

About Biomyf-S 360 Tablet

MYCOPHENOLATE SODIUM belongs to the class of medicine called 'immunosuppressant' that helps to prevent organ rejection after kidney transplant. Transplant rejection occurs when the recipient’s immune system identifies the transplanted organ as a ‘foreign object’ and attacks it. If it is not treated promptly, it may cause irreversible damage.

MYCOPHENOLATE SODIUM contains ‘mycophenolate sodium’ used in the treatment of organ transplant rejection along with another immunosuppressant and anti-inflammatory agent. It inhibits T and B lymphocytes (a type of white blood cells that attack foreign cells) and suppresses antibodie's production (identify and kill foreign cells). These effects suppress the immune system so that the transplanted graft is not rejected.

Uses of Biomyf-S 360 Tablet

Immunosuppressant therapy after organ (e.g. kidney) transplant

Medicinal Benefits of Biomyf-S 360 Tablet

MYCOPHENOLATE SODIUM contains ‘mycophenolate sodium’ which belongs to the class of ‘immunosuppressants’. It is used to prevent organ transplant rejection. It reduces the immune system's activity by inhibiting the action of white blood cells (responsible for immune reaction) in the body. It is preferred to use over steroids, which have long-term side-effects. MYCOPHENOLATE SODIUM is a gastro-resistant tablet which is a delayed-release tablet.

Directions for Use

Your doctor will prescribe for how long you need to take MYCOPHENOLATE SODIUM based on your medical condition. Take MYCOPHENOLATE SODIUM exactly as prescribed by the doctor. The tablet form of MYCOPHENOLATE SODIUM should be swallowed as a whole with a glass of water, do not break or chew the tablet. It is a gastro-resistant tablet that is delayed-release designed to withstand the gastric fluid and release the active substance(s) in the intestinal fluid.

Side Effects of Biomyf-S 360 Tablet

• Dizziness
• Headache
• Cough
• Respiratory infections
• Weakness (asthenia)
• Muscle pain (myalgia)
• Shortness of breath (dyspnoea)

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

Do not take MYCOPHENOLATE SODIUM if you are allergic to any immunosuppressant medicines or mycophenolate sodium. Let your doctor know before using MYCOPHENOLATE SODIUM if you have liver or kidney problems, severe digestive issues, cancer, liver disease (such as hepatitis B, hepatitis C), current/past infections, rare genetic disorders (such as Lesch-Nyhan or Kelley-Seegmiller syndromes). Do not take MYCOPHENOLATE SODIUM if you are pregnant or planning for pregnancy as MYCOPHENOLATE SODIUM is a Pregnancy category risk D medicines which can cause serious congenital disabilities to the unborn baby. MYCOPHENOLATE SODIUM should not be taken by breastfeeding mothers as it passes into breast milk. Pregnant women should use reliable forms of birth control while on treatment and for six weeks after stopping treatment with MYCOPHENOLATE SODIUM. While taking MYCOPHENOLATE SODIUM, do not contact anyone who has shingles, chickenpox, or measles. MYCOPHENOLATE SODIUM causes dizziness and drowsiness, so drive with caution. MYCOPHENOLATE SODIUM should not be given to children as safety and efficacy have not been established. Avoid consuming alcohol along with MYCOPHENOLATE SODIUM as it could lead to increased dizziness. Your doctor may advise you to undergo regular blood tests, kidney and liver tests to monitor your condition. Avoid excessive exposure to sunlight, wear protective clothing, and use protective sunscreen with a high protection factor while using MYCOPHENOLATE SODIUM.

Drug Interactions

Drug-Drug Interaction:

MYCOPHENOLATE SODIUM may have interaction with other immunosuppressant medicines (tacrolimus), medicines used to treat high blood cholesterol levels (cholestyramine), activated charcoal used to treat digestive problems, antacids containing magnesium and aluminium and medicines used to treat viral infections (aciclovir or ganciclovir).

Drug-Disease Interaction:

MYCOPHENOLATE SODIUM may cause interactions with disease conditions such as cancer, liver disease (such as hepatitis B, hepatitis C), current/past infections, serious digestive problems, rare genetic disorders (such as Lesch-Nyhan or Kelley-Seegmiller syndromes).

Safety Advice

ALCOHOL

You are recommended to avoid alcohol consumption while taking MYCOPHENOLATE SODIUM. It could lead to increased dizziness and drowsiness.

PREGNANCY

MYCOPHENOLATE SODIUM may cause birth defects and miscarriage if taken during pregnancy. Follow contraception advice given by your doctor if you are a woman who could become pregnant. Also, undergo a pregnancy test before starting treatment with MYCOPHENOLATE SODIUM.

BREAST FEEDING

It is not recommended to take MYCOPHENOLATE SODIUM while you are breastfeeding. MYCOPHENOLATE SODIUM passes into breast milk.

DRIVING

MYCOPHENOLATE SODIUM may cause dizziness, tiredness, do not drive or operate heavy machinery if you feel dizzy.

LIVER

Take MYCOPHENOLATE SODIUM only after the doctor's prescription, especially if you have liver diseases/conditions as your doctor may adjust the dose as required.

KIDNEY

Please consult your doctor if you have kidney impairment before taking MYCOPHENOLATE SODIUM as your doctor may adjust the dose as required.